Introduction
Methods
Literature Search
Criteria for Inclusion
Study Quality
Data Extraction
Data Analysis
Results
Search Strategy and Study Selection
Study | Year of publication | Clear definition of study population? | Clear description of patient characteristics? | Clear description of lesions? | Clear description of technique? | Follow-up complete? | Objective assessment of patency? | Clear definition of outcomes? | Suma
|
---|---|---|---|---|---|---|---|---|---|
London [20] | 1994 | + | + | + | + | − | +/− | + | 11 |
Reekers [2] | 1994 | + | + | + | + | +/− | +/− | +/− | 11 |
Nydahl [23] | 1997 | + | + | + | + | + | + | + | 14 |
McCarthy [21] | 2000 | + | + | + | − | +/− | + | + | 11 |
Vraux & Hammer [29] | 2000 | + | + | + | + | +/− | + | + | 13 |
Ingle [14] | 2002 | + | + | + | + | + | − | +/− | 11 |
Shaw [24] | 2002 | + | + | + | − | + | + | + | 12 |
Tisi [27] | 2002 | + | + | + | +/− | + | ? | + | 11 |
Laxdal [16] | 2003 | + | + | + | + | − | + | + | 12 |
Lipsitz [19] | 2003 | + | + | + | + | − | + | +/− | 11 |
Yilmaz [31] | 2003 | + | + | + | + | − | + | + | 12 |
Desgranges [11] | 2004 | + | + | + | + | − | + | +/− | 11 |
Florenes [12] | 2004 | + | + | +/− | + | + | + | − | 11 |
Hynes [13] | 2004 | + | +/− | + | − | + | + | + | 11 |
Lazaris & Tsiamis [17] | 2004 | + | + | + | − | − | ? | + | 8 |
Spinosa [26] | 2004 | + | + | + | + | +/− | +/− | + | 12 |
Smith [25] | 2005 | + | + | + | + | + | +/− | + | 13 |
Cho [10] | 2006 | + | + | + | + | − | + | + | 12 |
Kidd [15] | 2006 | + | + | + | + | + | + | + | 13 |
Lazaris & Salas [18] | 2006 | + | + | + | − | − | + | − | 8 |
Myers [22] | 2006 | + | + | +/− | + | + | + | + | 13 |
Treiman [28] | 2006 | + | + | + | + | + | + | + | 14 |
Vraux & Bertoncello [30] | 2006 | + | + | + | + | +/− | + | + | 13 |
Study Characteristics
Study | No. of patients, limbs | Fontaine grade | Patient age, yr (range) | Patient Characteristics | Location of lesions | Follow-up, mo (range) | |
---|---|---|---|---|---|---|---|
Lesion (mostly) in crural vessels | |||||||
Ingle [14] | 67, 70 | II | 6 (9%) | Mean: 76 (41–96) | DM: 31 (46%) | CA: 70 | (6–44) |
III | 21 (31%) | HT: 36 (54%) | |||||
IV | 40 (60%) | Smoking: 39 (58%) | |||||
Nydahl [23] | 27, 28 | III | 4 (14%) | Median: 81 (48–88) | DM: 9 (33%) | CA: 28 | No one lost to FU (18–48) |
IV | 24 (86%) | HT: 9 (33%) | |||||
Smoking: 4 (15%) | |||||||
Vraux & Hammer [29] | 36, 40 | III | 9 (23%) | Median: 70 (36–90) | DM: 26 (72%) | PA-CA: 8 (20%) | Median: 10 (1–24) |
IV | 31 (77%) | HT: 14 (39%) | CA: 32 (80%) | ||||
Smoking: unknown | |||||||
Vraux & Bertoncello [30] | 46, 50 | III | 4 (8%) | Median: 75 (35–92) | DM: 28 (61%) | PA-CA: 28 (56%) | Median: 15 (2–53) |
IV | 46 (92%) | HT: 33 (72%) | CA: 22 (44%) | ||||
Smoking: unknown | |||||||
Lesion (mostly) in femoral or femoropopliteal artery | |||||||
Hynes [13] | 74, 74 | III | 24 (32%) | Mean: 71 | DM: 17 (23%) | FA: 74 | Mean: 15 |
IV | 50 (68%) | HT: unknown | SD: 0.6 | ||||
Smoking: 42 (57%) | |||||||
Myers [22] | 78, 82 | II | 10 (12%) | Mean: 59 (42–88) | DM: 49 (63%) | FA: 82 | Mean: 10 |
III | 51 (62%) | HT: 59 (76%) | SD: 0.8 | ||||
IV | 21 (26%) | Smoking: 74 (95%) | |||||
Treiman [28] | 29, 29 | III | 16 (55%) | Mean: 71 (48–86) | DM: 16 (55%) | FA: 8 (28%) | Mean: 38 (28–54) |
IV | 13 (45%) | HT: 22 (76%) | FA-PA: 20 (69%) | ||||
Smoking: 17 (59%) | CA: 1 (3%) | ||||||
Mixed lesions (all infrainguinal) | |||||||
Lazaris & Tsiamis [17] | 99, 112 | III | 32 (29%) | Median: 79 (42–92) | DM: 40 (36%) | FA-PA: 62 (55%) | Mean: 20 (3–2) |
IV | 80 (71%) | HT: 54 (48%) | PA-CA: 33 (29%) | ||||
Smoking: 68 (61%) | FA-CA: 17 (15%) | ||||||
Lazaris & Salas [18] | 46, 51 | III | 14 (27%) | Median: 80 (43–95) | DM: 18 (39%) | FA-PA: 27 (53%) | 12 |
IV | 37 (73%) | HT: 25 (54%) | CA: 24 (47%) | ||||
Smoking: 22 (48%) | |||||||
Spinosa [26] | 40, 44 | III | 4 (9%) | Median: 69 (29–90) | DM: 24 (60%) | FA-PA: 7 (16%) | Median: 8 (1–24) |
IV | 40 (91%) | HT: unknown | CA: 15 (34%) | ||||
Smoking: unknown | FA-CA: 22 (50%) |
Study | No. of patients, limbs | Fontaine grade | Patient age, yr (range) | Patient characteristics | Location of lesions | Follow-up, mo (range) | |
---|---|---|---|---|---|---|---|
Lesion (mostly) in femoral or femoro-popliteal artery | |||||||
Kidd [15] | 43, 43 | II | 30 (71%) | Mean: 76 (50–95) | DM: 5 (12%) | FA-PA: 43 | After 1 yr, 18/42 at risk |
III | 10 (24%) | HT: 20 (46%) | |||||
IV | 2 (5%) | Smoking: 23 (54%) | |||||
Laxdal [16] | 109, 124 | II | 81 (65%) | Mean: 72 (35–92) | DM: 19/107 (18%) | FA-PA: 124 | Mean: 7 |
III/IV | 43 (35%) | HT: 47/108 (43%) | Median: 3 | ||||
Smoking: 55/100 (55%) | |||||||
McCarthy [21] | 66, 69 | II | 26 (38%) | Median: 74 (47–92) | DM: 20 (29%) | FA-PA: 69 | Median: 8 (1–29) |
III/IV | 43 (62%) | HT: 18 (26%) | |||||
Smoking: 18 (26%) | |||||||
Reekers [2] | 40, 40 | II | 11 (28%) | Mean: 69 (42–87) | DM: 5 (13%) | FA-PA: 40 | After 1 yr |
III | 24 (60%) | HT: 16 (40%) | 17/34 at risk | ||||
IV | 5 (13%) | Smoking: 27 (68%) | |||||
Shaw [24] | 46, 50 | II | 23 (46%) | Median: 72 (45–93) | DM: 14 (30%) | FA-PA: 48 (96%) | Median: 8 (6–11) |
III/IV | 27 (54%) | HT: 26 (57%) | CA 2 (4%) | ||||
Smoking: 34 (74%) | |||||||
Smith [25] | 43, 48 | II | 31 (65%) | Median: 73 (49–92) | DM: 10 (21%) | FA 48 | Median: 20 |
III/IV | 17 (35%) | HT: 22 (46%) | |||||
Smoking: 30 (63%) | |||||||
Yilmaz [31] | 61, 67 | II | 41 (67%) | Median: 61 | DM: 18 (30%) | FA 67 | Mean: 12.5 |
III | 18 (30%) | (37–75) | HT: 30 (49%) | SD: 9 | |||
IV | 2 (3%) | Mean: 61 | Smoking: 42 (69%) | (1–30) | |||
Mixed lesions (all infrainguinal) | |||||||
Cho [10] | 36, 40 | II | 18 (45%) | Mean: 71 | DM: 23 (64%) | IA: 2 (5%) | Median: 8 |
III | 2 (5%) | (57–83) | HT: 30 (83%) | FA-PA: 15 (38%) | Mean: 10 | ||
IV | 20 (50%) | Smoking: 20 (56%) | CA: 15 (38%) | (1–23) | |||
FA-CA 8 (20%) | |||||||
Desgranges [11] | 96, 100 | II | 46 (48%) | Mean: 72 | DM: 63 (66%) | FA-PA: 82 (82%) | Mean: 15 |
III/IV | 50 (52%) | (44–90) | HT: 69 (72%) | CA: 18 (18%) | 14 pts lost to FU | ||
Smoking: 62 (64%) | |||||||
Lipsitz [19] | 39, 39 | II | 9 (23%) | Median: 74 | DM: 22 (56%) | IA: 2 (5%) | After 1 yr, 46% |
III | 5 (13%) | (46–89) | HT: 20 (51%) | FA-PA: 31 (79%) | Lost to FU | ||
IV | 25 (64%) | Smoking: 14 (36%) | CA: 6 (15%) | ||||
Tisi [27] | 148, 158 | II | 29 (18%) | Median: 78 | DM: 43 (29%) | FA-PA: 122 (77%) | After 1 yr, 26/152 at risk |
III/IV | 129 (82%) | (70–82) | HT: 79 (53%) | CA: 36 (23%) | |||
Smoking: 106 (72%) |
Study | No. of patients, limbs | Fontaine grade | Patients age, yr (range) | Patient characteristics | Location of lesions | Follow-up, mo (range) | |
---|---|---|---|---|---|---|---|
Lesion (mostly) in femoral or femoral-popliteal artery | |||||||
London [20] | 176, 200 | II | 178 (89%) | Median: 68 (22–92) | DM: 33 (19%) | FA-PA: 200 | (3–60) |
III/IV | 22 (11%) | HT: 62 (35%) | |||||
Smoking: 61 (35%) | |||||||
Mixed lesions (all infrainguinal) | |||||||
Florenes [12] | 104, 116 | II | 116 (100%) | Mean: 67 (31–91) | DM: 9 (9%) | Inf-ing: 116 | Median: 41 (0–79) |
HT: 31 (30%) | |||||||
Smoking: 57 (55%) |
Technical Success
Clinical Success
Study | Statistical method | Clinical success (mo) | Complications | Primary patency (mo) | Primary assisted patency (mo) | Limb salvage (mo) | Survival (mo) |
---|---|---|---|---|---|---|---|
Lesion (mostly) in crural vessels | |||||||
Ingle [14] | KMA | – | 9/70 (13%) | – | – | 94% (12) | – |
Nydahl [23] | KMA | 56% (12) | 3/28 (11%) | 53% (12)a
| – | 85% (12) | – |
Vraux & Hammer [29] | KMA | 68% (12) | 5/40 (13%) | 56% (12)b
| – | 81% (12) | 78% (12) |
Vraux & Bertoncello [30] | KMA | 63% (12) | 7/50 (14%) | 46% (12)b
| – | 87% (12) | 65% (12) |
Lesion (mostly) in femoral or femoropopliteal artery | |||||||
Hynes [13] | LTA | – | 6/74 (8%) | – | – | – | – |
Myers [22] | KMA | – | 2/82 (2%) | 74% (3)a
| 87% (3) | – | – |
Treiman [28] | KMA | – | 4/29 (14%) | 64% (24)b
| – | 80% (24) | 50% (24) |
Mixed lesions (all infrainguinal) | |||||||
Lazaris & Tsiamis [17] | KMA | 69% (24) | 14/112 (13%) | – | – | 88% (12) | – |
Lazaris & Salas [18] | KMA | – | – | 50% (12)b
| – | 92% (12) | 87% (12) |
Spinosa [26] | KMA | – | 4/40 (10%) | – | – | 66% (12) | 71% (12) |
Study | Statistical method | Clinical success (mo) | Complications | Primary patency (mo) | Primary assisted patency (mo) | Limb salvage (mo) | Survival (mo) |
---|---|---|---|---|---|---|---|
Lesion (mostly) in femoral or femoro-popliteal artery | |||||||
Kidd [15] | LTA | – | – | 52% (12)a
| – | 100% (12) | 98% (12) |
Laxdal [16] | KMA | – | 9/124 (7%) | – | 37% (12) | 90% (7) | – |
McCarthy [21] | KMA | 60% (8) | 11/69 (16%) | 51% (6)a
| – | 88% (8) | 86% (6) |
Reekers [2] | LTA | 50% (12) | 8/40 (20%) | 59% (12)a
| – | – | – |
Shaw [24] | KMA | 59% (6) | 5/50 (10%) | 57% (6)a
| – | – | 89% (6) |
Smith [25] | KMA | – | 7/47 (15%) | 53% (12)a
| – | – | – |
Yilmaz [31] | KMA | – | 10/67 (15%) | 22% (12)a
| 57% (12) | – | 100% (12) |
Mixed lesions (all infrainguinal) | |||||||
Cho [10] | KMA | – | 4/40 (10%) | 44% (12)b
| – | – | – |
Desgranges [11] | LTA | – | 17/100 (17%) | 61% (24)a
| 69% (24) | 78% (24) | 85% (24) |
Lipsitz [19] | LTA | 68% (12) | 3/39 (8%) | 64% (12)b
| – | 92% (12) | – |
Tisi [27] | LTA | – | 26/158 (16%) | 45% (1)a
| – | – | – |
Study | Statistical method | Clinical success (mo) | Complications | Primary patency (mo) | Primary assisted patency (mo) | Limb salvage (mo) | Survival (mo) |
---|---|---|---|---|---|---|---|
Lesion (mostly) in femoral or femoro-popliteal artery | |||||||
London [20] | KMA | 58% (12) | 15/200 (8%) | 56% (12)a
| – | – | – |
Mixed lesions (all infrainguinal) | |||||||
Florenes [12] | KMA | – | 20/116 (17%) | – | 56% (36) | – | – |